Pure Global
NCT06067165

Primary Care Online Emotion-regulation Treatment (POET)

Karolinska Institutet·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mental Health Issue
Drug/Device/Intervention
POET feeling
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Karolinska Institutet
Location
Stockholm, Sweden
Timeline & enrollment
Phase
N/A
Start date
Oct 16, 2023
End date
Nov 25, 2031
Enrollment
388 participants
Primary outcome

The Clinical Global Impressions -Severity scale (CGI-S)

Summary

Mental health problems in youth are a global problem, causing incalculable suffering in youth
 and families, harming long-term prospects of youths, and creating substantial economic costs
 to society.
 
 The overall objective of this study is to build an evidence base for a highly scalable
 transdiagnostic intervention called the Primary care Online Emotion-regulation Treatment
 (POET) for youth (12-17 years) seeking treatment for mental health problems.
 
 In a randomized controlled trial, the investigators will examine the effects of POET. The
 investigators will test if emotion regulation mediates reduction in mental health problems
 during treatment. In addition the investigators will test if POET is more effective for some
 individuals than others and evaluate if POET is cost-effective. The investigators will also
 test whether there are detectable effects of POET on distal outcomes utilizing registry data
 following participants up to 10 years post treatment.

ICD-10 classifications
Mental disorder, not otherwise specifiedMental and behavioural disordersUnspecified mental disorderProblems related to certain psychosocial circumstancesProblems related to other psychosocial circumstances
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06067165
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06067165 through Pure Global AI's free database. This phase not specified trial is sponsored by Karolinska Institutet and is currently Recruiting. The study focuses on Mental Health Issue. Target enrollment is 388 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.